about
Molecular and histological changes following central retinal artery occlusion in a mouse model.Long-term ophthalmological follow-up of children with Parinaud syndrome.Lack of oncogenic GNAQ mutations in melanocytic lesions of the conjunctiva as compared to uveal melanoma.Fluorescence Lifetime Imaging Microscopy, a Novel Diagnostic Tool for Metastatic Cell Detection in the Cerebrospinal Fluid of Children with MedulloblastomaTranslational Preclinical Research may Lead to Improved Medical Management of Non-Arteritic Anterior Ischemic Optic Neuropathy.Mutational analysis of PTEN/PIK3CA/AKT pathway in oral squamous cell carcinoma.Oligodendrocyte dysfunction after induction of experimental anterior optic nerve ischemia.Preoperative Visual Loss is the Main Cause of Irreversible Poor Vision in Children with a Brain Tumor.Long term visual and neurological prognosis in patients with treated and untreated cavernous sinus aneurysms.BRAF, GNAQ, and GNA11 mutations and copy number in pediatric low-grade gliomaComparison of Neuroprotective Effect of Bevacizumab and Sildenafil following Induction of Stroke in a Mouse Model.Contralateral lateral rectus muscle recession in patients with Duane retraction syndrome type 3.Hypermethylation of CpG island loci of multiple tumor suppressor genes in retinoblastoma.The promise of stem cell-based therapeutics in ophthalmology.Severe cranial neuropathies caused by falls from heights in children.Acquired nystagmus as the initial presenting sign of chiasmal glioma in young children.Parainfectious optic neuritis: manifestations in children vs adults.Two distinct mechanisms mediate the involvement of bone marrow cells in islet remodeling: neogenesis of insulin-producing cells and support of islet recovery.Role of transesophageal echocardiography in the evaluation of patients with retinal artery occlusion.Relative neuroprotective effects hyperbaric oxygen treatment and TLR4 knockout in a mouse model of temporary middle cerebral artery occlusion.Retinal NFL thinning on OCT correlates with visual field loss in pediatric craniopharyngioma.PI3K/Akt pathway mutations in retinoblastoma.Intralesional and sub-Tenon's infusion of corticosteroids for treatment of refractory periorbital and orbital capillary haemangioma.Plasma ghrelin levels are normal in obese patients with idiopathic intracranial hypertension (pseudotumor cerebri).Lack of BRAF mutation in primary uveal melanoma.Bone Marrow Homing Enriches Stem Cells Responsible for Neogenesis of Insulin-Producing Cells, While Radiation Decreases Homing Efficiency.Effect of coadministration of neuronal growth factors on neuroglial differentiation of bone marrow-derived stem cells in the ischemic retina.Primitive stem cells derived from bone marrow express glial and neuronal markers and support revascularization in injured retina exposed to ischemic and mechanical damage.β-Cell neogenesis: experimental considerations in adult stem cell differentiation.Neurologic and ophthalmologic complications of vascular access in a hemodialysis patient.Gold Nanorods Based Air Scanning Electron Microscopy and Diffusion Reflection Imaging for Mapping Tumor Margins in Squamous Cell Carcinoma.Exome sequencing identified a novel de novo OPA1 mutation in a consanguineous family presenting with optic atrophy.Difficulty in Distinguishing Posterior Reversible Encephalopathy Syndrome, Hypoxic-Ischemic Insult, and Acute Toxic Leukoencephalopathy in Children.MicroRNA-mRNA expression profiles associated with medulloblastoma subgroup 4.Toll-like receptor-4 knockout mice are more resistant to optic nerve crush damage than wild-type mice.Reduction of apoptosis in ischemic retinas of two mouse models using hyperbaric oxygen treatment.Protective effect of Bax ablation against cell loss in the retinal ganglion layer induced by optic nerve crush in transgenic mice.Does haptoglobin genotype affect early onset of diabetic retinopathy in patients with type 2 diabetes?Increased plasma and optic nerve levels of IL-6, TNF-alpha, and MIP-2 following induction of ischemic optic neuropathy in mice.T1799A BRAF mutations in conjunctival melanocytic lesions.
P50
Q33353160-9220E536-DF7C-4CA1-AE91-6F9EE9F33F40Q33570847-55B1BB0C-E823-41F9-A13F-AED6A03DEA59Q33632948-020DD124-9CA5-46B1-8E15-8F57F96419DDQ33807896-2DD9B500-3FB5-4FD8-80FE-801CA91A5F16Q33883506-8C5FA478-845C-4AB5-B410-EE7690DE748EQ33985471-FEC7A573-85CF-497C-8D8A-477404463ED5Q34436993-AC5541B9-7C09-4DBB-A53D-E7D3FA3BFB18Q35243606-23E78F73-F157-4B85-B4BD-76BA36C99C88Q35481009-630D9296-35AB-4C56-AD71-4412482D8B5BQ36811872-C88350CB-7092-43DA-907D-36C44F74145BQ36995042-A8C899AD-5FDD-4C55-86D8-1C9FE547E0C5Q37663206-4A6FA492-5BC3-4FDB-8C60-66062E08D326Q38428715-76622632-43A4-42EF-B0F6-5C70057F948CQ39236145-D5FCD875-05F4-40D2-848E-31CED2E287C2Q40339383-2259A51A-B2FC-46D2-BA96-8E78D20E30E5Q41571623-31300EB6-ABD7-450F-8C6D-7135B3DF095EQ42222269-E01C1475-80DB-4D89-8443-A488E9F80D9EQ43483201-5D4129E9-0C77-4C02-BE57-6DF305E3DF7CQ43686206-392AB9F7-F595-4C48-B9B5-3D711E9BBD4EQ44993824-7CEFAB8B-CBC6-4B1D-8F45-5D1DB28A9890Q45194338-2BD776B7-8C02-41A5-989A-47F57EDA99DFQ46023205-84575318-04E8-4900-993B-4E8979AED420Q46260728-18458464-A546-4E3F-95F6-B5C5A060BD80Q47247308-A1CE570C-454B-4C1C-83B0-00A65EBA3240Q47807462-62D5364B-CD57-46BE-AB89-E2A6ACE9E4C7Q50268146-8280DAA5-6A72-46BA-9D10-862CDAF95444Q50465573-71DC2F7D-FF10-4E40-B0A4-AB36A5EC6E02Q50512676-E40CAE2C-CD22-43A3-90AC-3C9F9E62D1B3Q50537407-431EF4B9-A97C-4EDF-A951-86220247141CQ51009376-0C468C6F-F4D4-427B-8810-3FD7E7249D3CQ51564610-1C46E6CB-63FB-477B-93D5-37E43EAD7059Q51718729-38D6CC43-09F7-422A-A5FA-CDD25BF3916DQ52145230-64798248-1D66-4135-B5C5-D7BD4F36F630Q52678065-FDCFE932-D173-4222-AEA5-64DBB1B045C1Q53585154-84997BE0-29E5-48DD-B330-ECE5BD444B98Q54351858-A93A080E-4D7D-465D-83B3-DB8CBF4080F8Q54356821-D9A20E50-35E7-4BFF-A01C-2222F2F065B8Q54373983-084B9CC0-F6E4-43F2-B9ED-7CDA46FA4B49Q54538024-98779B70-6204-49DE-9869-BC7BA81D9C2DQ54646848-20DC15CD-6821-4665-9BFE-9CD293F17C60
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Nitza Goldenberg-Cohen
@ast
Nitza Goldenberg-Cohen
@en
Nitza Goldenberg-Cohen
@es
Nitza Goldenberg-Cohen
@nl
Nitza Goldenberg-Cohen
@sl
type
label
Nitza Goldenberg-Cohen
@ast
Nitza Goldenberg-Cohen
@en
Nitza Goldenberg-Cohen
@es
Nitza Goldenberg-Cohen
@nl
Nitza Goldenberg-Cohen
@sl
prefLabel
Nitza Goldenberg-Cohen
@ast
Nitza Goldenberg-Cohen
@en
Nitza Goldenberg-Cohen
@es
Nitza Goldenberg-Cohen
@nl
Nitza Goldenberg-Cohen
@sl
P1053
F-2936-2018
P106
P1153
6602893877
P31
P3829
P496
0000-0002-5648-1873